UTMD.OQ
Latest Trade
87.50USDChange
-0.32(-0.36%)Volume
1,976Today's Range
-
88.5852 Week Range
-
107.95As of on the NASDAQ ∙ Minimum 15 minute delay
Jan 28 (Reuters) - Utah Medical Products Inc <UTMD.O>::UTMD REPORTS AUDITED YEAR 2020 AND FOURTH QUARTER FINANCIAL PERFORMANCE.
Oct 27 (Reuters) - Utah Medical Products Inc <UTMD.O>::UTMD REPORTS FINANCIAL PERFORMANCE FOR THIRD QUARTER AND NINE MONTHS OF YEAR 2020.UTAH MEDICAL PRODUCTS INC - QTRLY NET SALES $ 10.5 MILLION VERSUS $ 12.5 MILLION.UTAH MEDICAL PRODUCTS INC - QTRLY DILUTED EPS $0.803.
July 28 (Reuters) - Utah Medical Products Inc <UTMD.O>::UTMD REPORTS FINANCIAL PERFORMANCE FOR SECOND CALENDAR QUARTER AND FIRST HALF 2020.UTAH MEDICAL PRODUCTS INC - QTRLY EARNINGS PER SHARE OF $0.359.
Nov 5 (Reuters) - Utah Medical Products Inc <UTMD.O>::UTAH MEDICAL PRODUCTS- INCREASING QUARTERLY DIVIDEND TO $0.28 PER SHARE, UP 2% OVER PRIOR QUARTER.
Oct 24 (Reuters) - Utah Medical Products Inc <UTMD.O>::UTMD REPORTS FINANCIAL PERFORMANCE FOR THIRD QUARTER AND NINE MONTHS OF YEAR 2019.Q3 EARNINGS PER SHARE $0.991.QTRLY NET SALES $12.5 MILLION VERSUS $10.4 MILLION.
July 30 (Reuters) - Utah Medical Products Inc <UTMD.O>::UTAH MEDICAL PRODUCTS, INC. REPORTS FINANCIAL PERFORMANCE FOR SECOND QUARTER 2019.UTAH MEDICAL PRODUCTS INC QTRLY EARNINGS PER SHARE $.944.UTAH MEDICAL PRODUCTS INC QTRLY NET SALES $11.9 MILLION, UP 8%.
April 25 (Reuters) - Utah Medical Products Inc <UTMD.O>::UTAH MEDICAL PRODUCTS, INC. REPORTS FINANCIAL PERFORMANCE FOR FIRST QUARTER 2019.UTAH MEDICAL PRODUCTS INC - QTRLY EARNINGS PER SHARE $0.840.UTAH MEDICAL PRODUCTS INC QTRLY EARNINGS PER SHARE $0.840.UTAH MEDICAL PRODUCTS INC QTRLY NET SALES $10.7 MILLION VERSUS $10.9 MILLION.
Utah Medical Products Inc <UTMD.O>::UTMD REPORTS AUDITED YEAR 2018 AND FOURTH QUARTER FINANCIAL PERFORMANCE.UTAH MEDICAL PRODUCTS INC QTRLY EARNINGS PER SHARE $0.905.UTAH MEDICAL PRODUCTS INC QTRLY NET SALES $9.8 MILLION VERSUS $10.2 MILLION.UTAH MEDICAL PRODUCTS INC QTRLY EPS BEFORE GILTI TAX$0.940.UTAH MEDICAL PRODUCTS INC - "EXPECTS WORLDWIDE MACROECONOMIC CONDITIONS TO WEAKEN, WHICH MAY AFFECT DEMAND FOR DISCRETIONARY SPECIALTY MEDICAL DEVICES".UTAH MEDICAL PRODUCTS INC - "CONTINUING TRADE WAR WITH CHINA COULD HAVE SIGNIFICANT ADVERSE EFFECTS ON UTMD".UTAH MEDICAL PRODUCTS INC - "ON SUBJECT OF BREXIT, UTMD DOES NOT FORESEE A MATERIAL IMPACT ON ITS FINANCIAL RESULTS IN 2019".UTAH MEDICAL PRODUCTS INC - CURRENTLY PROJECTS UTMD 2019 USD CONSOLIDATED REVENUES MAY BE IN RANGE OF 9-10% HIGHER THAN IN 2018.UTAH MEDICAL PRODUCTS INC - "CURRENTLY PROJECTS UTMD 2019 USD CONSOLIDATED REVENUES MAY BE IN RANGE OF 9-10% HIGHER THAN IN 2018".
Jan 7 (Reuters) - Utah Medical Products Inc <UTMD.O>::UTAH MEDICAL PRODUCTS SAYS ON DEC 31, CO & COOPERSURGICAL INC ENTERED DEFINITIVE AGREEMENT - SEC FILING.UTAH MEDICAL PRODUCTS - BASIC TERMS OF DEAL INCLUDE A UTMD CASH PAYMENT OF $21 MILLION TO CSI, PURCHASE OF CSI'S RESALEABLE INVENTORY.UTAH MEDICAL PRODUCTS - AGREEMENT TO BUY REMAINING 4.75 YEAR LIFE OF EXCLUSIVE DISTRIBUTION AGREEMENT BETWEEN COOPERSURGICAL AND FEMCARE LTD.UTAH MEDICAL PRODUCTS INC - AFTER FEB. 1, 2019, CSI WILL NO LONGER ACCEPT ORDERS OR SHIP FILSHIE CLIP SYSTEM DEVICES TO CUSTOMERS.
Oct 23 (Reuters) - Utah Medical Products Inc <UTMD.O>::UTAH MEDICAL PRODUCTS, INC. REPORTS FINANCIAL PERFORMANCE FOR THIRD QUARTER 2018.Q3 NON-GAAP EARNINGS PER SHARE $0.954.Q3 GAAP EARNINGS PER SHARE $1.802.QUARTERLY NET SALES $10.4 MILLION VERSUS $10.1 MILLION.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.